Evidence map›Paper›PMID 23470621›Full record

ArticleAmerican journal of respiratory cell and molecular biology2013

Hyperoxia and interferon-γ-induced injury in developing lungs occur via cyclooxygenase-2 and the endoplasmic reticulum stress-dependent pathway.

Rayman Choo-Wing, Mansoor A Syed, Anantha Harijith, Brianne Bowen, Gloria Pryhuber, Cecilia Janér, Sture Andersson, Robert J Homer, Vineet Bhandari

Open access · greenAbstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. COX2 inhibition in the treatment of COVID-19: Review of literature to propose repositioning of celecoxib for randomized controlled studies.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Rayman Choo-WingDivision of Perinatal Medicine, Department of Pediatrics, Yale University School of Medicine, New Haven, CT 06520, USA.
Mansoor A Syed
Anantha Harijith
Brianne Bowen
Gloria Pryhuber
Cecilia Janér
Sture Andersson
Robert J Homer
Vineet Bhandari
Yale University · USUniversity of Helsinki · FIPerinatal Institute · GBUniversity of Rochester · US

Funding

Role of Angiogenic Agents in Alveolar Maturation and InjuryR01HL085103 · NHLBI · YALE UNIVERSITY · PI BHANDARI, VINEET · 2009 to 2013
$2.0M
TNFR ASSOCIATED FACTOR IN PULMONARY RESPONSE TO TNF-AR01HL063039 · NHLBI · UNIVERSITY OF ROCHESTER · PI PRYHUBER, GLORIA S · 2000 to 2003
$1.1M
Angiogenic Agents and Alveolar InjuryK08HL074195 · NHLBI · YALE UNIVERSITY · PI BHANDARI, VINEET · 2003 to 2007
$664k
NHLBI NIH HHS HL63039NHLBI NIH HHS HL74195NHLBI NIH HHS HL85103NHLBI NIH HHS K08 HL074195NHLBI NIH HHS R01 HL063039NHLBI NIH HHS R01 HL085103
6 · The paper itself

Abstract

We noted a marked increase in cyclooxygenase-2 (Cox2) and the activation of the endoplasmic reticulum (ER) stress pathway in newborn murine lung on exposure to hyperoxia and IFN-γ. We sought to evaluate Cox2-mediated ER stress pathway activation in hyperoxia-induced and IFN-γ-mediated injury in developing lungs. We applied in vivo genetic gain-of-function and genetic/chemical inhibition, as well as in vitro loss-of-function genetic strategies. Hyperoxia-induced and IFN-γ-mediated impaired alveolarization was rescued by Cox2 inhibition, using celecoxib. The use of small interfering RNA against the ER stress pathway mediator, the C/EBP homologous protein (CHOP; also known as growth arrest and DNA damage-inducible gene 153/GADD153), alleviated cell death in alveolar epithelial cells as well as in hyperoxia-induced and IFN-γ-mediated murine models of bronchopulmonary dysplasia (BPD). In addition, CHOP siRNA also restored alveolarization in the in vivo models. Furthermore, as evidence of clinical relevance, we show increased concentrations of Cox2 and ER stress pathway mediators in human lungs with BPD. Cox2, via CHOP, may significantly contribute to the final common pathway of hyperoxia-induced and IFN-γ-mediated injury in developing lungs and human BPD.

Indexed as

Endoplasmic Reticulum StressAnimalsAnimals, NewbornBronchopulmonary DysplasiaCelecoxibCell DeathCyclooxygenase 2Cyclooxygenase 2 InhibitorsHumansHyperoxiaImmunohistochemistryInfant, NewbornInterferon-gammaLungMiceMice, Inbred C57BLCelecoxibCyclooxygenase 2Cyclooxygenase 2 InhibitorsDdit3 protein, mouseInterferon-gammaPtgs2 protein, mousePyrazolesRNA, Small InterferingSulfonamidesTranscription Factor CHOP

Identifiers

PMID23470621
PMCPMC3727872
OpenAlexW2141022932

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.